Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use

Numinus Wellness Inc.’s (OTCQX: NUMIF) (TSX: NUMI) research division, Numinus Bioscience, recently announced the development of a tea bag containing psilocybin for use in clinical research. If granted appropriate regulatory approvals, this could eventually be used as a treatment for clients in psychedelic-assisted therapy. Numinus strives to be at the cutting edge of psychedelic-assisted therapies that are both innovative and safe. Numinus VP, Scientific Research, Innovation & Laboratory Operations Sharan Sidhu said the Numinus team developed the Psilocybe tea bag with scientific precision in mind. The VP stated that the company’s best-in-class team and resources allow Numinus to control the full production The post Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use appeared first on Psychedelic Chronicle.